Skip to main content
SpringerLink
Log in

The role of cannabis in cognitive functioning of patients with schizophrenia

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Cognitive deficits are commonly found both in patients with schizophrenia (SCH) and in people with cannabis use disorders (CUD). Surprisingly, some small recent studies reported better cognitive performance in SCH patients with comorbid cannabis use disorders (SCH + CUD) compared to other SCH patients.

Objectives

The aim of the present study was to investigate the residual impact of CUD and specific patterns of consumption on cognition in a larger sample of SCH + CUD patients.

Methods

We administered a cognitive test battery to 34 SCH and 35 currently abstinent SCH + CUD patients. We explored the association between patterns of cannabis consumption and cognitive performance. Potential confounds with influence on cognitive ability were assessed and controlled for.

Results

SCH + CUD patients had poorer academic achievements and lower vocabulary scores, but they performed better in tests of verbal and working memory, visuomotor speed and executive function (p < .05). More frequent cannabis use was associated with better performance in attention and working memory tasks.

Conclusions

Although our findings might be interpreted as beneficial effect of cannabis use on cognition in patients with schizophrenia, we favorise an alternative interpretation: in our view, the better cognitive functioning of SCH + CUD patients may rather reflect a relatively lower vulnerability to psychosis compared to the SCH group. Lower vulnerability may correspond to a higher level of functioning such as cognitive ability. This conclusion is consistent with the view of cannabis playing a critical role in the manifestation of psychosis in at least some of the SCH + CUD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ajdacic-Gross V, Lauber C, Warnke I, Haker H, Murray RM, Rössler W (2007) Changing incidence of psychotic disorders among the young in Zurich. Schizophr Res 95:9–18

    Article  PubMed  Google Scholar 

  • APA–American Psychiatric Association, (2000) Diagnostic and Statistical Manual of Mental Disorders–DSM-IV-TR, Text Revision, 4th edn. American Psychiatric Association, Washington, DC

    Book  Google Scholar 

  • Arsenault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325:1212–1213

    Article  Google Scholar 

  • Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL (2002) Dose-related neurocognitive effects of marijuana use. Neurology 59:1337–1343

    PubMed  CAS  Google Scholar 

  • Boydell J, Van Os J, Lambri M, Castle D, Allardyce J, McCreadie RG, Murray RM (2003) Incidence of schizophrenia in south-east London between 1965 and 1997. Br J Psychiatry 182:45–49

    Article  PubMed  CAS  Google Scholar 

  • Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craiq IW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57:1117–1127

    Article  PubMed  CAS  Google Scholar 

  • Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L (1988) The Continuous Performance Test, Identical Pairs Version (CPT-IP): new findings about sustained attention in normal families. Psychiatry Res 26:223–228

    Article  PubMed  CAS  Google Scholar 

  • Coulston CM, Perdices M, Tennant CC (2007a) The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Schizophr Res 96:169–184

    Article  PubMed  Google Scholar 

  • Coulston CM, Perdices M, Tennent CC (2007b) The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Aust N Z J Psychiatry 41(11):869–884 Review

    Article  Google Scholar 

  • D´Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH (2005) Delta-9-Tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594–608

    Article  CAS  Google Scholar 

  • Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148:224–230

    PubMed  CAS  Google Scholar 

  • Drake RE, Mueser KT (2000) Psychosocial approaches to dual diagnosis. Schizophr Bull 26:105–118

    PubMed  CAS  Google Scholar 

  • Duke PJ, Phantelis C, McPhillips MA, Barnes TR (2001) Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central london. Br J Psychiatry 179:509–513

    Article  PubMed  CAS  Google Scholar 

  • Fergusson DM, Horwood LJ, Ridder EM (2005) Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100:354–366

    Article  PubMed  Google Scholar 

  • Gold JM, Carpender C, Randolph C, Goldberg T, Weinberger TR (1997) Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 54:159–165

    PubMed  CAS  Google Scholar 

  • Grant I, Gonzalez R, Carey CL, Natarajan L, Wolfson T (2003) Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol 9(5):679–689

    CAS  Google Scholar 

  • Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72:41–51

    Article  PubMed  Google Scholar 

  • Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J (2000) Neuroprotective antioxidants from marijuana. Ann N Y Acad Sci 899:274–282

    Article  PubMed  CAS  Google Scholar 

  • Harvey MA, Sellmann JD, Porter RJ, Framptom CM (2007) The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev 26(3):309–319

    Article  PubMed  Google Scholar 

  • Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficits in schizophrenia: a quantitative review of the evidence. Neuropsychol 12(3):426–445

    Article  CAS  Google Scholar 

  • Henquet C, Krabbendam L, Kaplan C, Lieb R, Wittchen HU (2005) Prospectice cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330:11–24

    Article  PubMed  Google Scholar 

  • Heubrock D (1992) Der Auditiv-Verbale Lerntest (AVLT) in der klinischen und experimentellen Neuropsychologie. Durchführung, Auswertung und Forschungsergebnisse. Zeitschrift für Differentielle und Diagnostische Psychologie 13:161–174

    Google Scholar 

  • Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB (2007) Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 102:597–606

    Article  PubMed  Google Scholar 

  • Jockers-Scherübl MC, Wolf T, Radzei N, Schlattmann P, Rentzsch J, Gomez-Carrillo de Castro A, Kühl KP (2007) Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 31:1054–1063

    Article  PubMed  CAS  Google Scholar 

  • Kay SR, Fiszbein A, Opler LA (1987) The positive and negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261–277

    PubMed  CAS  Google Scholar 

  • Keefe RSE, Fenton WS (2007) How should DSM-V criteria for schizophrenia include cognitive impairment. Schizophr Bull. 33(4):912–920

    Article  PubMed  Google Scholar 

  • Lehrl S (1995) Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B), 3 rdth edn. Hogrefe, Göttingen

    Google Scholar 

  • Lezak MD (1995) Neuropsychological Assessment, thirdth edn. Oxford University Press, Oxford

    Google Scholar 

  • Linszen D, van Amelsvoort T (2007) Cannabis and psychosis: an update on course and biological plausible mechanisms. Curr Opin Psychiatry 20:116–120

    Article  PubMed  Google Scholar 

  • Montgomery A, Asberg M (1979) A new depression rating scale designed to be sensitive to change. Br J Psychiatry 134:382–389

    Article  PubMed  CAS  Google Scholar 

  • Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental outcomes: a systematic review. Lancet 370:319–328

    Article  PubMed  Google Scholar 

  • Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull 16:31–56

    PubMed  CAS  Google Scholar 

  • Pope HG Jr, Gruber AJ, Yurgelun-Todd D (2001a) Residual neuropsychologic effects of cannabis. Curr Psychiatry Res 3:507–512

    Article  Google Scholar 

  • Pope HG Jr, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D (2001b) Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 56:909–915

    Article  Google Scholar 

  • Pope HG Jr, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D (2003) Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 69:303–310

    Article  PubMed  Google Scholar 

  • Potvin S, Joyal CC, Pelletier J, Stip E (2008) Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis. Schizophr Res 100(1–3):242–251

    Article  PubMed  Google Scholar 

  • Ranganathan M, D`Souza DC (2006) The acute effects of cannabinoids on memory in humans: a review. Psychopharmacol 188:425–444

    Article  CAS  Google Scholar 

  • Reitan RM (1955) The relation of the trail making test to organic brain damage. J Consult Psychol 19:393–394

    Article  PubMed  CAS  Google Scholar 

  • Reitan RM, Wolfson D (1993) The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation, 2nd edn. Neuropsychology Press, South Tucson

    Google Scholar 

  • Sarne Y, Mechoulam R (2005) Cannabinoids: between neuroprotection and neurotoxicity. Curr Drug Targets CNS Neurol Disord 4:677–684

    Article  PubMed  CAS  Google Scholar 

  • Sevy S, Burdick KE, Visweswaraiah H, Lukin M, Yechiam E, Bechara A (2007) Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders. Schizophr Res 92:74–84

    Article  PubMed  Google Scholar 

  • Snitz BE, Macdonald AW 3rd, Carter CS (2006) Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull 32:179–194

    Article  PubMed  Google Scholar 

  • Solowij N (1995) Do cognitive impairments recover following cessation of cannabis use? Life Sci 56(23–24):2119–2126

    Article  PubMed  CAS  Google Scholar 

  • Solowij N, Roffman RA, Barbor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287:1123–1131

    Article  PubMed  Google Scholar 

  • Solowij N, Michie PT (2007) Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia? J Psychiatr Neurosci 32(1):30–52

    Google Scholar 

  • Solowij N, Battisti R (2008) The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 1:81–98

    PubMed  Google Scholar 

  • Stirling J, Lewis S, Hopkins R, White C (2005) Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow up. Schizophr Res 75:135–137

    Article  PubMed  Google Scholar 

  • Tewes U (1991) Hamburg-Wechsler-Intelligenztest für Erwachsene - Revision, 2nd edn. Huber, Bern

    Google Scholar 

  • Tsuang MT, Simpson JC, Kronfol Z (1982) Subtypes of drug abuse with psychosis. Arch Gen Psychiatry 39:141–147

    PubMed  CAS  Google Scholar 

  • Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G (2002) Self reported cannabis use as risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 325:1199–1204

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors want to thank Laura Kranaster, Sonja Gross, Karsten Heekeren, Knut Schnell and Anna Neukirch for their assistance in recruiting the subjects. In addition, the authors want to thank Ralf Pukrop for his help in selecting the neuropsychological tests. Finally, we want to thank Karsten Blume for his assistance in testing the subjects.

Conflict of interest

The authors declare that they have no conflicts of interest.

Role of funding source

Funding sources did not play any role in conducting or reporting this research.

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, University Hospital of Cologne, Kerpener Str. 62, 50924, Cologne, Germany

    Thomas Schnell, Dagmar Koethe, Jörg Daumann & Euphrosyne Gouzoulis-Mayfrank

Authors
  1. Thomas Schnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dagmar Koethe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jörg Daumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Euphrosyne Gouzoulis-Mayfrank
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Euphrosyne Gouzoulis-Mayfrank.

Electronic supplementary materials

Below is the link to the electronic supplementary material.

ESM 1

(DOC 147 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schnell, T., Koethe, D., Daumann, J. et al. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology 205, 45–52 (2009). https://doi.org/10.1007/s00213-009-1512-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-009-1512-9

Keywords

Search

Navigation